{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8L925",
      "entity_text" : "CRC",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04170",
      "entity_text" : "rs2304497",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We found that in patients with advanced stage tumor (stage III + IV), the heterozygous variant (WV) and homozygous variant (VV) genotypes in both rs2304497 and rs9912300 reduced the death risk of CRC in the dominant model (HR = 0.47, 95% CI = 0.24-0.90 and HR = 0.59, 95% CI = 0.37-0.92, respectively).",
  "reading_complete" : "2020-08-02T15:32:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:30:26Z",
  "trigger" : "reduced",
  "evidence" : [ "rs2304497 and rs9912300 reduced the death risk of CRC" ],
  "pmc_id" : "4359538",
  "score" : 0
}